Meena Narayanan, PhD, received her doctorate from Medical University of Vienna, Austria, where she studied the immunological mechanisms underlying the boost of secondary antibody responses using molecules containing B cell epitopes. After her brief experience working for a pharmaceutical company, Narayanan joined the Arditi Laboratory to work with Magali Noval Rivas, PhD, studying the role of microbiome and mucosal immunology in shaping systemic immune responses, particularly focused on how these systems contribute to the development of cardiovascular lesions in Kawasaki disease.
Begum Kocaturk, PhD, received her doctorate from the Thrombosis and Hemostasis Department at Leiden University, Netherlands, where she worked on the impact of coagulation factors in cancer progression. Upon completion of her doctorate, Kocaturk worked as a postdoctoral fellow at National Nanotechnology Research Center, Bilkent University, Ankara, Turkey, where her research focused on emergency room stress-dependent gene expression profile in the development of atherosclerosis. She joined the Arditi Laboratory in 2018 and is working with Magali Noval Rivas, PhD, on the role of innate immunity, platelets, and the complement system in the development of cardiovascular lesions in the experimental mouse model of Kawasaki disease vasculitis. Kocaturk is also working with Moshe Arditi, MD, on the molecular and cellular immune mechanisms involved in the acceleration of atherosclerosis after Kawasaki disease in the mouse model.
Kyle Madrid is a doctoral candidate in biomedical science and translational medicine in the Cedars-Sinai PhD program studying in the Arditi Laboratory. For his undergraduate degree, Madrid transferred from Fresno City College to the University of California, Riverside, in 2013. He studied photocatalytic semiconductors in the nanomaterial synthesis lab of Yadong Yin, PhD. Madrid received his bachelor of science in biochemistry in 2015. His current project in the Arditi Lab focuses on the influence of IL-1β on smooth muscle proliferation in Kawasaki disease utilizing tissue-specific IL-1β receptor knockout mice. He is also investigating the role of IL-12, IL-17 and IL-22 in the experimental mouse model of Kawasaki disease vasculitis. He is funded by a National Institutes of Health F31 grant, mentored by Moshe Arditi, MD.